NRx Pharmaceuticals (NRXP)
4.48
+0.02 (0.45%)
Upcoming Events
Latest Headlines
Form 8-K NRX Pharmaceuticals, For: Jul 21
July 22, 2026 7:00 AM - SEC Filing
New to The Street Announces Broadcast of Show #759 on Bloomberg Television Across the U.S., MENA and Latin America tonight 630pm est.
June 27, 2026 2:40 PM - StreetInsider
NRx Pharmaceuticals disputes Kadima claims amid arbitration
June 25, 2026 4:01 PM - StreetInsider
NRx Pharmaceuticals Responds to Recent Public Statements Regarding Kadima Dispute
June 25, 2026 4:01 PM - StreetInsider
HOPE Therapeutics begins patient TMS treatments with Zeta navigation
June 25, 2026 7:00 AM - StreetInsider
NRx Pharmaceuticals (Nasdaq: NRXP) Subsidiary HOPE Therapeutics Treats First Patients Using Zeta Surgical's FDA-Cleared Zeta TMS Navigation System
June 25, 2026 7:00 AM - Globe NewsWire
NRx Pharmaceuticals (Nasdaq: NRXP) Subsidiary HOPE Therapeutics Treats First Patients Using Zeta Surgical's FDA-Cleared Zeta TMS Navigation System
June 25, 2026 7:00 AM - StreetInsider
Kadima sues NRx Pharmaceuticals over failed acquisition deal
June 24, 2026 1:19 PM - StreetInsider
Kadima Neuropsychiatry Institute Files Suit Against NRx Pharmaceuticals (NASDAQ: NRXP), Alleging Breach of Contract and Misrepresentation in Connection with Acquisition
June 24, 2026 1:18 PM - BizWire
Zeta Surgical begins TMS navigation treatments at Hope Therapeutics clinics
June 23, 2026 11:10 AM - StreetInsider
ZETA SURGICAL® Announces Successful Treatment of First Patient with Zeta TMS Navigation System at HOPE Therapeutics
June 23, 2026 11:05 AM - PR NewsWire
NRx Pharmaceuticals Announces FDA Grant of Expanded Access Protocol for Use of D-Cycloserine-based NRX-101 for Augmentation of Transcranial Magnetic Stimulation in the Treatment of Depression
June 22, 2026 7:00 AM - StreetInsider
New to The Street broadcasts show #758 TODAY AT 6:30 PM ET on BLOOMBERG TELEVISION ACROSS THE UNITED STATES, LATIN AMERICA, AND MENA
June 20, 2026 1:30 PM - StreetInsider
Osmind study finds IV ketamine more effective than nasal esketamine for depression
June 5, 2026 8:52 AM - StreetInsider
NRx Pharmaceuticals (Nasdaq:NRXP) notes presentation by Osmind, Inc. of IV Ketamine Efficacy vs. Nasal esketamine Efficacy at American Society of Clinical Psychopharmacology.
June 5, 2026 8:50 AM - Globe NewsWire
Form 8-K NRX Pharmaceuticals, For: Jun 03
June 4, 2026 5:20 PM - SEC Filing
NRX Pharmaceuticals closes $22.3 million stock offering
June 4, 2026 5:12 PM - StreetInsider
NRx Pharmaceuticals, Inc. Announces Closing of $22.3 Million Public Offering of Common Stock and Including Exercise of the Underwriters’ Option
June 4, 2026 5:12 PM - Globe NewsWire
Form 424B5 NRX Pharmaceuticals,
June 3, 2026 4:11 PM - SEC Filing
NRx Pharmaceuticals prices public offering at $3.50 per share
June 3, 2026 8:18 AM - StreetInsider
NRx Pharmaceuticals, Inc. Announces Pricing of Public Offering of Common Stock
June 3, 2026 8:18 AM - Globe NewsWire
Form 8-K NRX Pharmaceuticals, For: Jun 02
June 2, 2026 5:30 PM - SEC Filing
Form 424B5 NRX Pharmaceuticals,
June 2, 2026 5:28 PM - SEC Filing
NRx Pharmaceuticals announces proposed public offering of common stock
June 2, 2026 4:01 PM - StreetInsider
NRx Pharmaceuticals, Inc. Announces Proposed Public Offering of Common Stock
June 2, 2026 4:01 PM - StreetInsider
NRx Pharmaceuticals (Nasdaq: NRXP) Strategic Partner Emobot Presents Late-Breaking Clinical Validation of the EMOCARE Depression Thermometer at ASCP 2026
May 28, 2026 7:00 AM - StreetInsider
HOPE Therapeutics deploys Zeta Surgical's FDA-cleared TMS system
May 27, 2026 7:02 AM - StreetInsider
NRx Pharmaceuticals (Nasdaq: NRXP) Subsidiary HOPE Therapeutics Becomes First Commercial Site to Deploy Zeta Surgical's FDA-Cleared Zeta TMS Navigation System
May 27, 2026 7:00 AM - Globe NewsWire
NRx Pharmaceuticals (Nasdaq: NRXP) Subsidiary HOPE Therapeutics Becomes First Commercial Site to Deploy Zeta Surgical's FDA-Cleared Zeta TMS Navigation System
May 27, 2026 7:00 AM - StreetInsider
Form 25-NSE NRX Pharmaceuticals, Filed by: Nasdaq Stock Market LLC
May 22, 2026 4:18 PM - SEC Filing
NRx Pharmaceuticals (NRXP) Reports In-Line Q1 EPS
May 18, 2026 7:52 AM - StreetInsider
NRx Pharmaceuticals (Nasdaq:NRXP) Reports First Quarter 2026 Financial Results and Provides Corporate Update
May 18, 2026 7:00 AM - Globe NewsWire
New to The Street's Show #753 Airs Nationwide on Bloomberg Television Across the U.S., MENA and Latin America Featuring FreeCast (NASDAQ:CAST), Stardust Power (NASDAQ:SDST), Lost Soldier Oil and Gas,
May 16, 2026 7:05 AM - StreetInsider
Form 10-Q NRX Pharmaceuticals, For: Mar 31
May 15, 2026 4:36 PM - SEC Filing
Form SCHEDULE 13G/A NRX Pharmaceuticals, Filed by: Anson Funds Management LP
May 15, 2026 12:29 PM - SEC Filing
NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) to Report First Quarter 2026 Financial Results and Provide Corporate Update
May 14, 2026 7:00 AM - Globe NewsWire
NRx Pharmaceuticals receives FDA clearance for depression trial
May 7, 2026 8:01 AM - StreetInsider
NRx Pharmaceuticals (Nasdaq:NRXP) Announces FDA Clearance to Proceed with Clinical Trial of NRX-101 in Combination with Robotic-enabled Transcranial Magnetic Stimulation in Patients with Depression an
May 7, 2026 8:00 AM - Globe NewsWire
NRX Pharmaceuticals begins commercial manufacturing for preservative-free ketamine
May 5, 2026 7:00 AM - StreetInsider
NRx Pharmaceuticals (Nasdaq:NRXP) Announces Initiation of Commercial Manufacturing for Preservative Free Ketamine
May 5, 2026 7:00 AM - Globe NewsWire
GLOBAL MARKETS SPOTLIGHT: New to The Street Show #748 Delivers High-Impact CEO Interviews and Spotlight TV Commercials Across Bloomberg to 250M+ Households Worldwide
May 1, 2026 2:30 PM - StreetInsider
H.C. Wainwright Reiterates Buy Rating on NRx Pharmaceuticals, Inc. (NRXP)
April 27, 2026 6:49 AM - StreetInsider
New to The Street Broadcasts Show #746 Tonight on Bloomberg Television 6:30PM EST Featuring NRx Pharma (NASDAQ:NRXP), Performance Golf, Lost Soldier Oil & Gas, Dr. Lee Gause, and CISO Global
April 25, 2026 12:55 PM - StreetInsider
Full Article List
